Should Amway prioritize expanding its Nutrilite vitamin line with new formulations or focus on improving the taste and texture of existing products?

Introduction

The trade-off we're examining today is whether Amway should prioritize expanding its Nutrilite vitamin line with new formulations or focus on improving the taste and texture of existing products. This scenario involves balancing innovation with product refinement in the competitive health supplement market. I'll analyze this trade-off by considering market dynamics, consumer preferences, and Amway's strategic objectives.

Step 1

Clarifying Questions (3 minutes)

• Based on recent market trends, I'm thinking there might be a shift in consumer preferences towards more specialized vitamin formulations. Could you share any insights on how our current Nutrilite product line is performing in terms of market share and growth rates?

Why it matters: Helps determine if expansion or improvement is more urgent Expected answer: Stable market share but slowing growth in core products Impact on approach: Would lean towards new formulations if growth is stagnating

• Considering our business model, I'm assuming direct selling is still our primary distribution channel. Has there been any significant change in our sales force's feedback regarding customer satisfaction with existing products?

Why it matters: Indicates whether taste/texture issues are affecting sales Expected answer: Mixed feedback, with some complaints about taste Impact on approach: Would prioritize product improvement if widespread issue

• Looking at our user segments, I'm thinking we might have different preferences between our long-term customers and newer health-conscious consumers. Do we have data on the demographic breakdown of our customer base and their purchasing behaviors?

Why it matters: Helps tailor strategy to most valuable or growing segments Expected answer: Aging core customer base, but growing younger segment Impact on approach: Might suggest a two-pronged approach to serve both groups

• Regarding our R&D capabilities, I'm curious about our current pipeline for new formulations. How robust is our innovation funnel, and what's our typical time-to-market for new vitamin products?

Why it matters: Assesses feasibility and speed of expansion strategy Expected answer: Moderate pipeline with 12-18 month development cycle Impact on approach: Longer cycles might favor improving existing products

• Considering resource allocation, I'm wondering about our current marketing budget split between promoting existing products and launching new ones. Could you provide some context on how we typically balance these efforts?

Why it matters: Indicates potential for supporting either strategy Expected answer: 70/30 split favoring existing products Impact on approach: Might suggest reallocating resources for expansion